Pneumonia risk in diabetic patients to be reduced by SGLT2 inhibitors

Published On 2022-01-06 11:29 GMT | Update On 2022-01-06 11:29 GMT

Diabetic patients are 3 times more likely to die with flu and pneumonia. Yet, only one third of them ever get a simple, safe pneumonia shot. Pneumonia is a serious illness for anyone, but highly riskier with a history of diabetics.

Patients with type 2 diabetes using SGLT2 inhibitors are at a significantly lower risk of pneumonia and pneumonia mortality versus those using DPP4 Iinhibitors, reveals a reent study. The study was published in the Journal of Clinical Endocrinology and Metabolism on 08 November 2021.

Sodium glucose co-transporter 2 inhibitors (SGLT2is) are the latest class of glucose-lowerinf agents that have shown to reduce pneumonia risk in clinical trials. However, not much is known about the real-world effectiveness of SGLT2is on the risk of pneumonia.

To determine the same, Ching-Lung Cheung, The University of Hong Kong, Hong Kong SAR, China, and the team aimed to investigate the associations between SGLT2is use and the risk of pneumonia and pneumonia mortality versus dipeptidyl peptidase-4 inhibitors (DPP4is) using an electronic medical database in Hong Kong in a retrospective cohort study.

For more information check out the full story on the link below:

SGLT2 inhibitors use tied to lower pneumonia risk in diabetics: Study

Full View

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Nandita Mohan

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Pneumonia risk in diabetic patients to be reduced by SGLT2 inhibitors

Similar News

Glipizide and Metformin FDC - Effective, Safe and Cost-Effective in T2D: Latest Indian Real-World Study

Hepatitis B Vaccine May Lower Diabetes Risk: Study Finds

The Prediabetes Show, Episode 4: Metformin in Prediabetes - A Vaccination Pill for Diabetes Prevention in 65 Countries

New Research Reveals Diabetes May Accelerate Breast Cancer Growth

The Prediabetes Show Episode 3 - Tackling Patient Conversations around Prediabetes and Metformin

Mediterranean Diet Combined With Lifestyle Changes May Lower Diabetes Risk By 31 Percent: Study Shows

Study Reveals Your Brain Burns Fat at Night to Prevent Sugar Crashes

Body Type Influences How Fasting Affects Metabolism, Study Finds